A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021
- PMID: 35272931
- PMCID: PMC8900606
- DOI: 10.1016/j.jcf.2022.02.014
A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021
Conflict of interest statement
Declaration of Competing Interest H.L. Barr reports grants from NIHR (NIHR202952), CF Trust (VIA061), CF Foundation (pilot and feasiblity award) and Vertex Pharmaceuticals (ISS-2020-109445, IIS-2018-106697), A.M. Zwitserloot reports grants from Vertex Pharmaceuticals (IIS-2018-107391), H.L. Barr, T. Bihouee, A.M. Zwitserloot participated in the Advance program, financially supported by Vertex Pharmaceuticals.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical